Patient and consumer groups urged FDA to get a better handle on the performance of devices modified following an original approval or clearance, and they supported FDA oversight of laboratory developed tests during an Oct. 26 user fee reauthorization update meeting, according to meeting minutes
posted by
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?